Skip to main content
. 2020 Jan 27;51(2):549–555. doi: 10.1161/STROKEAHA.119.025554

Table 1.

Unweighted and Weighted Baseline Characteristics in Patients Treated With Rivaroxaban (N=6876) and Warfarin (N=13 597)

graphic file with name str-51-549-g001.jpg